PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
AHCO vs. LIN
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between AHCO and LIN is 0.21, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.2

Performance

AHCO vs. LIN - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in AdaptHealth Corp. (AHCO) and Linde plc (LIN). The values are adjusted to include any dividend payments, if applicable.

-25.00%-20.00%-15.00%-10.00%-5.00%0.00%5.00%10.00%AugustSeptemberOctoberNovemberDecember2025
-8.31%
-3.56%
AHCO
LIN

Key characteristics

Sharpe Ratio

AHCO:

0.72

LIN:

0.44

Sortino Ratio

AHCO:

1.43

LIN:

0.69

Omega Ratio

AHCO:

1.19

LIN:

1.09

Calmar Ratio

AHCO:

0.52

LIN:

0.44

Martin Ratio

AHCO:

3.91

LIN:

1.04

Ulcer Index

AHCO:

11.12%

LIN:

6.31%

Daily Std Dev

AHCO:

60.35%

LIN:

14.83%

Max Drawdown

AHCO:

-83.84%

LIN:

-51.76%

Current Drawdown

AHCO:

-74.17%

LIN:

-11.90%

Fundamentals

Market Cap

AHCO:

$1.40B

LIN:

$203.46B

EPS

AHCO:

-$1.67

LIN:

$13.19

Total Revenue (TTM)

AHCO:

$2.40B

LIN:

$24.72B

Gross Profit (TTM)

AHCO:

$345.04M

LIN:

$9.98B

EBITDA (TTM)

AHCO:

$460.01M

LIN:

$9.26B

Returns By Period

In the year-to-date period, AHCO achieves a 8.93% return, which is significantly higher than LIN's 2.06% return.


AHCO

YTD

8.93%

1M

8.59%

6M

-8.31%

1Y

49.64%

5Y*

-1.88%

10Y*

N/A

LIN

YTD

2.06%

1M

-1.84%

6M

-3.56%

1Y

5.77%

5Y*

16.68%

10Y*

15.40%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

AHCO vs. LIN — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

AHCO
The Risk-Adjusted Performance Rank of AHCO is 7474
Overall Rank
The Sharpe Ratio Rank of AHCO is 7474
Sharpe Ratio Rank
The Sortino Ratio Rank of AHCO is 7474
Sortino Ratio Rank
The Omega Ratio Rank of AHCO is 7373
Omega Ratio Rank
The Calmar Ratio Rank of AHCO is 7272
Calmar Ratio Rank
The Martin Ratio Rank of AHCO is 7979
Martin Ratio Rank

LIN
The Risk-Adjusted Performance Rank of LIN is 6161
Overall Rank
The Sharpe Ratio Rank of LIN is 6666
Sharpe Ratio Rank
The Sortino Ratio Rank of LIN is 5555
Sortino Ratio Rank
The Omega Ratio Rank of LIN is 5555
Omega Ratio Rank
The Calmar Ratio Rank of LIN is 6868
Calmar Ratio Rank
The Martin Ratio Rank of LIN is 6161
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

AHCO vs. LIN - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for AdaptHealth Corp. (AHCO) and Linde plc (LIN). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for AHCO, currently valued at 0.72, compared to the broader market-2.000.002.000.720.44
The chart of Sortino ratio for AHCO, currently valued at 1.43, compared to the broader market-4.00-2.000.002.004.001.430.69
The chart of Omega ratio for AHCO, currently valued at 1.19, compared to the broader market0.501.001.502.001.191.09
The chart of Calmar ratio for AHCO, currently valued at 0.52, compared to the broader market0.002.004.006.000.520.44
The chart of Martin ratio for AHCO, currently valued at 3.91, compared to the broader market0.0010.0020.003.911.04
AHCO
LIN

The current AHCO Sharpe Ratio is 0.72, which is higher than the LIN Sharpe Ratio of 0.44. The chart below compares the historical Sharpe Ratios of AHCO and LIN, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-0.500.000.501.001.502.00AugustSeptemberOctoberNovemberDecember2025
0.72
0.44
AHCO
LIN

Dividends

AHCO vs. LIN - Dividend Comparison

AHCO has not paid dividends to shareholders, while LIN's dividend yield for the trailing twelve months is around 1.30%.


TTM20242023202220212020201920182017201620152014
AHCO
AdaptHealth Corp.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
LIN
Linde plc
1.30%1.33%1.24%1.43%1.22%1.46%1.64%2.11%2.04%2.56%2.79%2.01%

Drawdowns

AHCO vs. LIN - Drawdown Comparison

The maximum AHCO drawdown since its inception was -83.84%, which is greater than LIN's maximum drawdown of -51.76%. Use the drawdown chart below to compare losses from any high point for AHCO and LIN. For additional features, visit the drawdowns tool.


-80.00%-60.00%-40.00%-20.00%0.00%AugustSeptemberOctoberNovemberDecember2025
-74.17%
-11.90%
AHCO
LIN

Volatility

AHCO vs. LIN - Volatility Comparison

AdaptHealth Corp. (AHCO) has a higher volatility of 12.70% compared to Linde plc (LIN) at 4.68%. This indicates that AHCO's price experiences larger fluctuations and is considered to be riskier than LIN based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


5.00%10.00%15.00%20.00%25.00%30.00%AugustSeptemberOctoberNovemberDecember2025
12.70%
4.68%
AHCO
LIN

Financials

AHCO vs. LIN - Financials Comparison

This section allows you to compare key financial metrics between AdaptHealth Corp. and Linde plc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab